共 50 条
- [1] PHASE II TRIAL OF HYPERFRACTIONATED INTENSITY-MODULATED RADIATION THERAPY AND CONCURRENT WEEKLY CISPLATIN FOR STAGE III AND IVa HEAD-AND-NECK CANCER [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (04): : 1081 - 1088
- [2] Phase II trial of hyperfractionated IMRT and concurrent cisplatin for stage III and IV head and neck cancer: Early quality of life analysis [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S397 - S398
- [3] Toxic cure: Hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for stage III and IVA head-and-neck cancer in the community [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (03): : 698 - 704
- [7] Long term results of a phase II trial of hyperfractionated radiation and intraarterial cisplatin (HYPERRADPLAT) on stage III-IV head and neck cancer with bulky primary tumors [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S429 - S429